论文部分内容阅读
目的研究甲泼尼松龙治疗重症支气管哮喘的临床效果。方法选取重症支气管哮喘患者42例,随机分为观察组和对照组,每组21例,观察组患者给予甲泼尼松龙治疗,对照组患者给予地塞米松治疗,比较两组患者重症支气管哮喘治疗效果及不良反应差异。结果观察组治疗总有效率95.2%,明显高于对照组治疗总有效率76.2%,对照组患者动脉氧分压高于观察组,观察组患者不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论甲泼尼松龙能够显著缓解重症支气管哮喘症状,不良反应少,减轻患者痛苦,提高临床治疗效果,值得推广应用。
Objective To study the clinical effect of methylprednisolone in the treatment of severe bronchial asthma. Methods Forty-two patients with severe bronchial asthma were randomly divided into observation group and control group, 21 cases in each group. Patients in observation group were treated with methylprednisolone, while those in control group were treated with dexamethasone. Patients with severe bronchial asthma Treatment effect and adverse reaction difference. Results The total effective rate of observation group was 95.2%, significantly higher than that of control group, the total effective rate was 76.2%. The arterial oxygen pressure of control group was higher than that of observation group. The incidence of adverse reactions in observation group was lower than that of control group Significance (P <0.05). Conclusion Methylprednisolone can significantly alleviate the symptoms of severe bronchial asthma, fewer side effects, reduce the suffering of patients and improve the effect of clinical treatment, it is worth promoting the application.